GlaxoSmithKline
GSK
$39.75
Share price
1.22%
Change (1 day)
7.64%
Change (1 year)
Categories
Number of shares outstanding for GlaxoSmithKline (GSK)
Number of shares outstanding as of April 2024 : 2,028,000,000
According to GlaxoSmithKline's latest financial reports and stock price the company's current number of shares outstanding is 2,028,000,000. At the end of 2023 the company had 2,028,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for GlaxoSmithKline from 2022 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 2.02 B | 0.55% |
| 2022 | 2.01 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 2,062,000,000 | 1.68% | 🇨🇭 Switzerland |
 Pfizer PFE | 5,647,000,000 | 178.45% | 🇺🇸 USA |
 Sanofi SNY | 2,507,200,000 | 23.63% | 🇫🇷 France |
 Merck MRK | 2,554,166,667 | 25.95% | 🇺🇸 USA |
 AstraZeneca AZN | 3,098,000,000 | 52.76% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 1,121,000,000 | -44.72% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | 128,988,000 | -93.64% | 🇺🇸 USA |